BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 27001435)

  • 21. Challenges in the treatment of parathyroid carcinoma: a case report.
    Russo M; Borzì G; Ilenia M; Frasca F; Malandrino P; Gullo D
    Hormones (Athens); 2019 Sep; 18(3):325-328. PubMed ID: 30905030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias.
    Gill AJ; Clarkson A; Gimm O; Keil J; Dralle H; Howell VM; Marsh DJ
    Am J Surg Pathol; 2006 Sep; 30(9):1140-9. PubMed ID: 16931959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer.
    Cetani F; Banti C; Pardi E; Borsari S; Viacava P; Miccoli P; Torregrossa L; Basolo F; Pelizzo MR; Rugge M; Pennelli G; Gasparri G; Papotti M; Volante M; Vignali E; Saponaro F; Marcocci C
    Endocr Connect; 2013; 2(4):186-95. PubMed ID: 24145611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of malignant parathyroid tumours in two European cohorts of patients with sporadic primary hyperparathyroidism.
    Ozolins A; Narbuts Z; Vanags A; Simtniece Z; Visnevska Z; Akca A; Wirowski D; Gardovskis J; Strumfa I; Goretzki PE
    Langenbecks Arch Surg; 2016 Nov; 401(7):943-951. PubMed ID: 26658808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor suppressor gene mutation in a patient with a history of hyperparathyroidism-jaw tumor syndrome and healed generalized osteitis fibrosa cystica: a case report and genetic pathophysiology review.
    Parfitt J; Harris M; Wright JM; Kalamchi S
    J Oral Maxillofac Surg; 2015 Jan; 73(1):194.e1-9. PubMed ID: 25511968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A family case report of parathyroid carcinoma associated with
    Gu Y; Ye Y; Shu H; Chang L; Xie Y; Li F; Zhu T; Liu M; He Q
    Front Endocrinol (Lausanne); 2024; 15():1330185. PubMed ID: 38348418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism.
    Bricaire L; Odou MF; Cardot-Bauters C; Delemer B; North MO; Salenave S; Vezzosi D; Kuhn JM; Murat A; Caron P; Sadoul JL; Silve C; Chanson P; Barlier A; Clauser E; Porchet N; Groussin L;
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E403-8. PubMed ID: 23293331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperparathyroidism 2 gene (HRPT2, CDC73) and parafibromin studies in two patients with primary hyperparathyroidism and uncertain pathological assessment.
    Cetani F; Pardi E; Ambrogini E; Banti C; Viacava P; Borsari S; Bilezikian JP; Pinchera A; Marcocci C
    J Endocrinol Invest; 2008 Oct; 31(10):900-4. PubMed ID: 19092296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Understanding the genetic basis of parathyroid carcinoma.
    Gill AJ
    Endocr Pathol; 2014 Mar; 25(1):30-4. PubMed ID: 24402736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic role of parafibromin staining and CDC73 mutation in patients with parathyroid carcinoma: A systematic review and meta-analysis based on individual patient data.
    Zhu R; Wang Z; Hu Y
    Clin Endocrinol (Oxf); 2020 Apr; 92(4):295-302. PubMed ID: 31945198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenotype of Parathyroid-targeted
    Costa-Guda J; Cohen ST; Romano R; Acostamadiedo J; Clark K; Bellizzi J; Arnold A
    J Endocr Soc; 2024 Jan; 8(3):bvae006. PubMed ID: 38328479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumors.
    Newey PJ; Bowl MR; Cranston T; Thakker RV
    Hum Mutat; 2010 Mar; 31(3):295-307. PubMed ID: 20052758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetics and Epigenetics of Parathyroid Carcinoma.
    Marini F; Giusti F; Palmini G; Perigli G; Santoro R; Brandi ML
    Front Endocrinol (Lausanne); 2022; 13():834362. PubMed ID: 35282432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathological correlates of hyperparathyroidism.
    Duan K; Gomez Hernandez K; Mete O
    J Clin Pathol; 2015 Oct; 68(10):771-87. PubMed ID: 26163537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genotype of CDC73 germline mutation determines risk of parathyroid cancer.
    Li Y; Zhang J; Adikaram PR; Welch J; Guan B; Weinstein LS; Chen H; Simonds WF
    Endocr Relat Cancer; 2020 Sep; 27(9):483-494. PubMed ID: 32590342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Should parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma?
    Cetani F; Ambrogini E; Viacava P; Pardi E; Fanelli G; Naccarato AG; Borsari S; Lemmi M; Berti P; Miccoli P; Pinchera A; Marcocci C
    Eur J Endocrinol; 2007 May; 156(5):547-54. PubMed ID: 17468190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Para This, Fibromin That: The Role of CDC73 in Parathyroid Tumors and Familial Tumor Syndromes.
    Ababneh E; Nosé V
    Surg Pathol Clin; 2023 Mar; 16(1):97-105. PubMed ID: 36739170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma.
    Shattuck TM; Välimäki S; Obara T; Gaz RD; Clark OH; Shoback D; Wierman ME; Tojo K; Robbins CM; Carpten JD; Farnebo LO; Larsson C; Arnold A
    N Engl J Med; 2003 Oct; 349(18):1722-9. PubMed ID: 14585940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surveillance for early detection of aggressive parathyroid disease: carcinoma and atypical adenoma in familial isolated hyperparathyroidism associated with a germline HRPT2 mutation.
    Kelly TG; Shattuck TM; Reyes-Mugica M; Stewart AF; Simonds WF; Udelsman R; Arnold A; Carpenter TO
    J Bone Miner Res; 2006 Oct; 21(10):1666-71. PubMed ID: 16995822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CDC73/HRPT2 CpG island hypermethylation and mutation of 5'-untranslated sequence are uncommon mechanisms of silencing parafibromin in parathyroid tumors.
    Hahn MA; Howell VM; Gill AJ; Clarkson A; Weaire-Buchanan G; Robinson BG; Delbridge L; Gimm O; Schmitt WD; Teh BT; Marsh DJ
    Endocr Relat Cancer; 2010 Mar; 17(1):273-82. PubMed ID: 20026646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.